41 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 34365218 | Predicting response to platinum and non-platinum drugs through bioluminescence resonance energy transfer (BRET) based bio-molecular interactions in platinum resistant epithelial ovarian cancer. | 2021 Nov | 2 |
2 | 34685613 | 7-Epitaxol Induces Apoptosis and Autophagy in Head and Neck Squamous Cell Carcinoma through Inhibition of the ERK Pathway. | 2021 Oct 2 | 3 |
3 | 31293426 | Tetramethylpyrazine Enhances the Antitumor Effect of Paclitaxel by Inhibiting Angiogenesis and Inducing Apoptosis. | 2019 | 1 |
4 | 31334335 | FoxM1 Induced Paclitaxel Resistance via Activation of the FoxM1/PHB1/RAF-MEK-ERK Pathway and Enhancement of the ABCA2 Transporter. | 2019 Sep 27 | 2 |
5 | 31786845 | Effect of PD98059 on chemotherapy in patients with colorectal cancer through ERK1/2 pathway. | 2019 Sep-Oct | 2 |
6 | 30064123 | Synergistic Anticancer Activity of Combined Use of Caffeic Acid with Paclitaxel Enhances Apoptosis of Non-Small-Cell Lung Cancer H1299 Cells in Vivo and in Vitro. | 2018 | 1 |
7 | 30094097 | Trametinib suppresses chemotherapy-induced cold and mechanical allodynia via inhibition of extracellular-regulated protein kinase 1/2 activation. | 2018 | 2 |
8 | 30221728 | Combination of pristimerin and paclitaxel additively induces autophagy in human breast cancer cells via ERK1/2 regulation. | 2018 Nov | 1 |
9 | 30429459 | Sulforaphane metabolites reduce resistance to paclitaxel via microtubule disruption. | 2018 Nov 14 | 1 |
10 | 28415580 | The N-terminal polypeptide derived from viral macrophage inflammatory protein II reverses breast cancer epithelial-to-mesenchymal transition via a PDGFRα-dependent mechanism. | 2017 Jun 6 | 1 |
11 | 29371916 | The IL-17B-IL-17 receptor B pathway promotes resistance to paclitaxel in breast tumors through activation of the ERK1/2 pathway. | 2017 Dec 26 | 1 |
12 | 27422607 | DUSP1 induces paclitaxel resistance through the regulation of p-glycoprotein expression in human ovarian cancer cells. | 2016 Sep 9 | 2 |
13 | 27563006 | Anti-nociceptive roles of the glia-specific metabolic inhibitor fluorocitrate in paclitaxel-evoked neuropathic pain. | 2016 Oct | 1 |
14 | 27619088 | Electrochemical approach for monitoring the effect of anti tubulin drugs on breast cancer cells based on silicon nanograss electrodes. | 2016 Sep 28 | 1 |
15 | 23478574 | Egr-1 enhances drug resistance of breast cancer by modulating MDR1 expression in a GGPPS-independent manner. | 2013 Apr | 2 |
16 | 23879997 | [Molecular mechanism of chemosensitization to paclitaxel in human melanoma cells induced by targeting the EGFR signaling pathway]. | 2013 Mar | 1 |
17 | 21391217 | Synergistic anti-tumor activity of isochaihulactone and paclitaxel on human lung cancer cells. | 2012 Jan | 3 |
18 | 21924351 | CDK1, not ERK1/2 or ERK5, is required for mitotic phosphorylation of BIMEL. | 2012 Jan | 1 |
19 | 22005063 | Paclitaxel induced B7-H1 expression in cancer cells via the MAPK pathway. | 2011 Oct | 2 |
20 | 19717209 | Potentiation of paclitaxel-induced apoptosis by galectin-13 overexpression via activation of Ask-1-p38-MAP kinase and JNK/SAPK pathways and suppression of Akt and ERK1/2 activation in U-937 human macrophage cells. | 2009 Dec | 1 |
21 | 18487950 | Differential impact of fibroblasts on the efficient cell death of lung cancer cells induced by paclitaxel and cisplatin. | 2008 Aug | 1 |
22 | 18594523 | Chemosensitisation by manganese superoxide dismutase inhibition is caspase-9 dependent and involves extracellular signal-regulated kinase 1/2. | 2008 Jul 22 | 1 |
23 | 18688857 | Toll-like receptor-4 is expressed in meningiomas and mediates the antiproliferative action of paclitaxel. | 2008 Oct 15 | 2 |
24 | 17400763 | Hypoxia inhibits paclitaxel-induced apoptosis through adenosine-mediated phosphorylation of bad in glioblastoma cells. | 2007 Jul | 1 |
25 | 17936423 | Cytoskeletal signaling by way of alpha-actinin-1 mediates ERK1/2 activation by repetitive deformation in human Caco2 intestinal epithelial cells. | 2007 Nov | 1 |
26 | 16395709 | p38 MAPK turns hepatocyte growth factor to a death signal that commits ovarian cancer cells to chemotherapy-induced apoptosis. | 2006 Jun 15 | 2 |
27 | 16397234 | Paclitaxel-induced nuclear translocation of FOXO3a in breast cancer cells is mediated by c-Jun NH2-terminal kinase and Akt. | 2006 Jan 1 | 2 |
28 | 15590693 | Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival. | 2005 Feb 11 | 2 |
29 | 15592521 | A novel CYR61-triggered 'CYR61-alphavbeta3 integrin loop' regulates breast cancer cell survival and chemosensitivity through activation of ERK1/ERK2 MAPK signaling pathway. | 2005 Jan 27 | 1 |
30 | 15657900 | Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (paclitaxel)-induced cytotoxicity. | 2005 May 20 | 2 |
31 | 15688426 | Novel indication for cancer therapy: Chk1 inhibition sensitizes tumor cells to antimitotics. | 2005 Jul 1 | 1 |
32 | 15778245 | MAP kinases in lung endothelial permeability induced by microtubule disassembly. | 2005 Jul | 1 |
33 | 15834684 | Paclitaxel impairs endothelial cell adhesion but not cytokine-induced cellular adhesion molecule expression. | 2005 May | 1 |
34 | 14742744 | Extracellular signal-regulated kinase/mitogen-activated protein kinases block internalization of delta-opioid receptors. | 2004 May | 1 |
35 | 15466208 | Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab. | 2004 Oct 1 | 1 |
36 | 12555062 | Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosis. | 2003 Jan 30 | 1 |
37 | 14688474 | Sequence dependent exposure of mammary carcinoma cells to Taxotere and the MEK1/2 inhibitor U0126 causes enhanced cell killing in vitro. | 2003 Nov-Dec | 1 |
38 | 11461121 | The role of ERK 1/2 and p38 MAP-kinase pathways in taxol-induced apoptosis in human ovarian carcinoma cells. | 2001 Aug 1 | 6 |
39 | 11710832 | Cross-talk between signalling pathways and the multidrug resistant protein MDR-1. | 2001 Oct 19 | 2 |
40 | 10773023 | Extracellular signal-regulated kinases are involved in the antiapoptotic effect of endothelin-1. | 2000 May | 2 |
41 | 10376521 | Serine protease inhibitor TPCK prevents Taxol-induced cell death and blocks c-Raf-1 and Bcl-2 phosphorylation in human breast carcinoma cells. | 1999 Jun 10 | 4 |